St George’s, University of London research has found that a drug normally given to osteoporosis sufferers could provide effective pain relief to patients with knee and hip osteoarthritis.
Bisphosphonates are a group of drugs known to change the structure of bone and are most often prescribed to patients with osteoporosis, a condition characterised by fragile bones.
It is unknown, however, whether these drugs could be used to reduce pain and discomfort for patients with the joint condition osteoarthritis, which causes cartilage damage, bony growths and sore tissue.
The researchers used existing studies to assess the effectiveness of a variety of bisphosphonates in patients suffering from osteoarthritis of the hand, knee, spine and hips.
Of 3832 patients studied, in most cases these drugs showed limited pain relief. However, a few studies did show benefit; the bisphosphonate alendronate was found to be more effective for patients with hip osteoarthritis than existing pain relieving drugs. Moreover, the use of zoledronate and alendronate, specific forms of bisphosphonates, improved pain in patients with knee and hip osteoarthritis at six months —but longer term studies are needed.
Dr Nidhi Sofat, lead researcher, said: “Osteoarthritis is the most common form of arthritis worldwide. It causes damage to bone and cartilage in the joints of affected people. Most treatment is focused around pain relief, as no robust treatments have been discovered that slow down the progression of the disease.
“Our study looked at whether there were any bisphosphonate drugs that have been shown to influence pain and/or disease progression that could be used in osteoarthritis treatment.
“We found that, generally, bisphosphonates are ineffective at managing pain associated with osteoarthritis. But zoledronate and alendronate, which are specific forms of bisphosphonates, do show the potential for effective pain management specifically in patients with knee and hip osteoarthritis.
The Latest on: Bisphosphonates
A Prospective, Observational Study of Osteoporosis in Men.
on April 22, 2018 at 12:00 am
All the patients with osteopenia and osteoporosis were advised lifestyle interventions, supplementation with calcium carbonate (1000-1500 mg/day) and 25-hydroxyl-Vitamin D (400-600 IU/day) and bisphosphonates if indicated. Vitamin D3 60,000 IU once a week ... […]
Bisphosphonates, IBS and diet, CRP test for infection, Randomisation
on April 17, 2018 at 5:00 pm
Clarification of new evidence that Bisphosphonates for osteoporosis may actually weaken bones if people are left on them for too long ; Dietary change using FODMAPS to treat Irritable bowel syndrome when medicines have not worked; CRP testing for chest ... […]
Steroid-Induced Bone Loss Better Treated With Denosumab?
on April 10, 2018 at 9:10 am
The RANKL inhibitor denosumab (Prolia, Amgen) is more efficacious than the bisphosphonate risedronate in boosting bone mineral density (BMD) at the lumbar spine in patients just starting or continuing steroid therapy, a new international, randomized ... […]
Warning over use of bisphosphonates in young racehorses
on April 8, 2018 at 11:51 am
The risk to young horses of a class of drugs known as bisphosphonates were discussed by delegates at a recent forum on racing-related equine welfare in Arizona. Bisphosphonates can prevent loss of bone-density and might have some therapeutic value for ... […]
Amgen's (AMGN) Xgeva Gets EU Approval for Expanded Label
on April 3, 2018 at 6:17 am
Bone complications in patients with multiple myeloma can be quite damaging. Until now, bisphosphonates were the only treatment option available for bone protection in multiple myeloma patients. However, bisphosphonates may cause renal toxicity and lead to ... […]
New Cautions About Long-Term Use of Bone Drugs
on May 8, 2012 at 5:00 pm
The F.D.A. review, published in The New England Journal of Medicine online on Wednesday, was prompted by a growing debate over how long women should continue using the drugs, known as bisphosphonates, which are sold as generic versions of brands like ... […]
Bisphosphonates Most Effective With Higher Vitamin D Levels
on September 21, 2011 at 2:58 pm
For most osteoporosis drug trials, participants are also placed on vitamin D supplementation, and some studies have suggested that the efficacy of bisphosphonates could depend on levels of circulating vitamin D. To more closely examine the relationship in ... […]
Bisphosphonates Cause Rare Eye Inflammation
on September 23, 2008 at 5:00 pm
WEDNESDAY, Sept. 24 (HealthDay News) -- Doctors can now add inflammatory eye disease to the list of potential side effects from the bone medications known as bisphosphonates. Though exceedingly rare -- only four cases have been reported in the medical ... […]
Experts Outline Use of Bisphosphonates Against Myeloma
on May 22, 2007 at 5:00 pm
WEDNESDAY, May 23 (HealthDay News) -- Bone-strengthening drugs called bisphosphonates can help some patients fight the marrow cancer multiple myeloma, according to new guidelines from the American Society of Clinical Oncology. Multiple myeloma is caused by ... […]
via Google News and Bing News